Merck & Company Inc. (MRK)

Merck & Company Inc. (MRK $121.57)
- $121.57 P/E (TTM): 16.05X Cap: $301.34B
- View MRK Profile
- View Questions on MRK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Chubb Limited (CB $330.58)
- $330.58 P/E (TTM): 13.57X Cap: $127.88B
- View CB Profile
- View Questions on CB
Mastercard Incorporated (MA $522.49)
- $522.49 P/E (TTM): 31.38X Cap: $462.27B
- View MA Profile
- View Questions on MA
Merck & Company Inc. (MRK $121.57)
- $121.57 P/E (TTM): 16.05X Cap: $301.34B
- View MRK Profile
- View Questions on MRK
Procter & Gamble Company (The) (PG $159.26)
- $159.26 P/E (TTM): 23.71X Cap: $372B
- View PG Profile
- View Questions on PG
Visa Inc. (V $319.84)
- $319.84 P/E (TTM): 29.49X Cap: $601.78B
- View V Profile
- View Questions on V
Toronto-Dominion Bank (The) (TD $129.90)
- $129.90 P/E (TTM): 11.11X Cap: $221.81B
- View TD Profile
- View Questions on TD
Bank of Nova Scotia (The) (BNS $103.72)
- $103.72 P/E (TTM): 25.35X Cap: $128.08B
- View BNS Profile
- View Questions on BNS
- View Reports on BNS
Canadian National Railway Company (CNR $148.73)
- $148.73 P/E (TTM): 19.87X Cap: $89.52B
- View CNR Profile
- View Questions on CNR
Enbridge Inc. (ENB $69.83)
- $69.83 P/E (TTM): 28.03X Cap: $159.88B
- View ENB Profile
- View Questions on ENB
- View Reports on ENB
Intact Financial Corporation (IFC $263.25)
- $263.25 P/E (TTM): 19.04X Cap: $46.73B
- View IFC Profile
- View Questions on IFC
Hydro One Limited (H $57.06)
- $57.06 P/E (TTM): 26.06X Cap: $33.86B
- View H Profile
- View Questions on H
Exxon Mobil CDR (CAD Hedged) (XOM $26.55)
- $26.55 P/E (TTM): 18.93X Cap: $860.68B
- View XOM Profile
- View Questions on XOM

Q: Hi 5i Team,

Can you suggest 5 Canadian and 5 US Value stocks that you would buy in order of high to low and the rational behind it. Please also include the entry price.

Thanks
Joe

Read Answer Asked by Joe on February 05, 2026

Merck & Company Inc. (MRK $121.57)
- $121.57 P/E (TTM): 16.05X Cap: $301.34B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $27.39)
- $27.39 P/E (TTM): 16.03X Cap: $156.81B
- View PFE Profile
- View Questions on PFE

Q: Given the sector's relative under performance, I believe the timing is right to increase my portfolio weighting in the Healthcare Sector. I own MRK and PFE. As I started to research individual companies it became apparent my lack of expertise in the area and the pace of technological advance makes stock picking in this area challenging. As such I'm considering an ETF and am currently looking at RSPH. Do you agree with the timing and would you advise an ETF or another individual company? If the former, what do you think of RSPH and if the latter' what would recommend for global exposure to the sector

Thank-you

Any input appreciated,

Read Answer Asked by jeff on February 02, 2026

Intuitive Surgical Inc. (ISRG $490.87)
- $490.87 P/E (TTM): 61.73X Cap: $172.53B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $476.61)
- $476.61 P/E (TTM): 32.14X Cap: $124.69B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $231.82)
- $231.82 P/E (TTM): 176.72X Cap: $409.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $243.08)
- $243.08 P/E (TTM): 22.07X Cap: $586.68B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,042.53)
- $1,042.53 P/E (TTM): 45.32X Cap: $981.09B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.57)
- $121.57 P/E (TTM): 16.05X Cap: $301.34B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $173.22)
- $173.22 P/E (TTM): 20.63X Cap: $8.52B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $629.67)
- $629.67 P/E (TTM): 49.91X Cap: $50.25B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $80.44)
- $80.44 P/E (TTM): 16.72X Cap: $9.34B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $100.39)
- $100.39 P/E (TTM): 15.77X Cap: $20.12B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.65)
- $24.65 P/E (TTM): 14.15X Cap: $2.99B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $31.80)
- $31.80 P/E (TTM): 407.84X Cap: $263.07B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026